BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 19, 2025
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Financings for Sept. 8, 2020

Sep. 8, 2020
Biopharmas raising money in public or private financings, including: Algenex, Graybug, Immunovant, Inversago, Manifold, PMV, Prelude.
Read More

Appointments and advancements for Sept. 8, 2020

Sep. 8, 2020
New hires and promotions in the biopharma industry, including: Advaxis, Cavogene, Fibrogen, Imcyse, Metrion, PMV, Tmunity.
Read More

Regulatory actions for Sept. 4, 2020

Sep. 4, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Roche.
Read More

Other news to note for Sept. 4, 2020

Sep. 4, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 54gene, Ascyrus Medical, Cryolife, Ehave, Feinstein Institute, Illumina, Infosys, Kaleidoscope Innovation, Novacyt, Ocular Therapeutix, Organovo, Orthopaedic Innovation Centre, Precipio, T2 Biosystems.
Read More

In the clinic for Sept. 4, 2020

Sep. 4, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Gelesis, Medmira.
Read More

Financings for Sept. 4, 2020

Sep. 4, 2020
Med-tech firms raising money in public or private financings, including: Applied UV.
Read More

Appointments and advancements for Sept. 4, 2020

Sep. 4, 2020
New hires and promotions in the med-tech industry, including: Varex Imaging.
Read More

Regulatory actions for Sept. 4, 2020

Sep. 4, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ascendis, Kite, Lilly.
Read More

Other news to note for Sept. 4, 2020

Sep. 4, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arcturus, Bioaegis, Curevac, Nanoviricides, Organovo.
Read More

In the clinic for Sept. 4, 2020

Sep. 4, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alligator, Amag, Ampio, Biontech, Blade, Crinetics, Hutchison China Meditech, Lexicon, Mesoblast, Oncopeptides, Relay, Savara.
Read More
Previous 1 2 … 1458 1459 1460 1461 1462 1463 1464 1465 1466 … 1720 1721 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 19, 2025.
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 19, 2025.
  • Rare disease illustration

    Rare earth: Biomarin to use global reach post-$4.8B Amicus buy

    BioWorld
    Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing